Treating COVID-19 could lead to increased antimicrobial resistance

The use of antibiotics in people with COVID-19 could result in increased resistance to the drugs’ benefits among the wider population, a new study suggests.

The level of antibiotic use with coronavirus patients adds to the problem of increased antibiotic resistance.

The findings are based on reports that up to 95% of COVID-19 inpatients are being prescribed antibiotics as part of their treatment, and concerns that such a large-scale drug administration could have wider environmental implications.